Excited for the 2nd publication this year through collaborative efforts with Harper Cancer Research Institute’s Karen Dahl (Title: CD133 Promotes Adhesion to the Ovarian Cancer Metastatic Niche). I did the 3D confocal imaging that showed CD133+ ovarian cancer cells clearly penetrate the basal epithelial cells, pointing to metastatic potential of stem cell like cancer cells. Looking forward to publishing more data this year on using novel bi-modal nanoprobes for targeted imaging of CD133+ ovarian cancer stem cells in vitro and in an in vivo model system.
« Society for Biomaterials (SFB) 2018 SYMPOSIUM
College of Science Joint Annual Meeting (CoS-JAM) Poster Presentation (May 4, 2018) »
May 01
CD133+ Cancer Stem Cells Role in Metastasis
Categories:
Berthiaume Institute for Precision Health, Biomedical Imaging, Cancer stem cells, Fluorescence, Harper Cancer Research Institute, Upcoming manuscripts
by Prakash
This post has no tag
Recent Posts
- Phage-Mimicking Antibacterial Nanoparticles Tackle Group A Streptococcal Infections In Vivo January 29, 2024
- 2nd Annual Berthiaume Institute for Precision Health’s Advisory Board Meeting October 30, 2023
- 1st Place Poster at the Military Health Sciences Research Symposium 2023 (Aug 14-17, Kissimmee, FL) August 14, 2023
- Congratulations to Ms. Johanna Olesk on Defending her MS (Bioengineering) ’23 Thesis July 7, 2023
- Translational Science to Impact Public Health was our Goal at Techconnect 2023 June 17, 2023
Archives
Categories
NIH Funding Opportunities
- NINDS Policy for applications requesting $500,000 or more in direct costs in any year (excluding consortium F and A)on NIH Parent R01 Notices of Funding Opportunities April 26, 2024Notice NOT-NS-24-079 from the NIH Guide for Grants and Contracts
- NHLBI Outstanding Investigator Award (OIA) (R35 Clinical Trial Optional) April 26, 2024Funding Opportunity RFA-HL-26-002 from the NIH Guide for Grants and Contracts. The purpose of the NHLBI Outstanding Investigator Award (OIA) is to promote scientific productivity and innovation by providing long-term support and increased flexibility to experienced Program Directors/Principal Investigators (PDs/PIs) who are currently PDs/PIs on at least two NHLBI R01-equivalent awards and whose outstanding record […]
- NHLBI Emerging Investigator Award (EIA) (R35 Clinical Trial Optional) April 26, 2024Funding Opportunity RFA-HL-26-003 from the NIH Guide for Grants and Contracts. The purpose of the NHLBI Emerging Investigator Award (EIA) is to promote scientific productivity and innovation by providing long-term support and increased flexibility to experienced Program Directors/Principal Investigators (PDs/PIs) who are currently PDs/PIs on at least two NHLBI R01-equivalent awards and whose outstanding record […]
- Coordinating Center for Type 1 Diabetes TrialNet (U01 Clinical Trial Required) April 26, 2024Funding Opportunity RFA-DK-25-004 from the NIH Guide for Grants and Contracts. The purpose of this Notice of Funding Opportunity (NOFO) is to continue support for the TrialNet Coordinating Center (TNCC). The TrialNet network identifies people with type 1 diabetes (T1D) at stages before and after onset of clinical symptoms and enrolls them in trials and […]
- NIDCD Individual Fellowship Pre-Application Information Session April 26, 2024Notice NOT-DC-24-026 from the NIH Guide for Grants and Contracts
- Notice of Special Interest (NOSI): Administrative Supplement to Support the NCI Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) Research April 26, 2024Notice NOT-CA-24-047 from the NIH Guide for Grants and Contracts
- Small Business Transition Grant for New Entrepreneurs (R43/R44 Clinical Trial Required) April 26, 2024Funding Opportunity PAR-24-132 from the NIH Guide for Grants and Contracts. Through this Notice of Funding Opportunity (NOFO), the National Institutes of Health (NIH) aims to facilitate the career development and transition of investigators new to entrepreneurship with an interest in small business by simultaneously supporting their entrepreneurial development and the conduct of research and […]
- Independent Scientist Award (Parent K02 Independent Basic Experimental Studies with Humans Required) April 26, 2024Funding Opportunity PA-24-180 from the NIH Guide for Grants and Contracts. The purpose of the NIH Independent Scientist Award (K02) is to foster the development of outstanding scientists and enable them to expand their potential to make significant contributions to their field of research. The K02 award provides three to five years of salary support […]
- Independent Scientist Award (Parent K02 - Independent Clinical Trial Required) April 26, 2024Funding Opportunity PA-24-178 from the NIH Guide for Grants and Contracts. The purpose of the NIH Independent Scientist Award (K02) is to foster the development of outstanding scientists and enable them to expand their potential to make significant contributions to their field of research. The K02 award provides three to five years of salary support […]
- Notice of Budget Change in RFA-AI-24-006 Centers for Research in Emerging Infectious Diseases (CREID) Network (U01 Clinical Trial Not Allowed) April 25, 2024Notice NOT-AI-24-046 from the NIH Guide for Grants and Contracts
Recent Comments